0 likes | 9 Views
In an insightful discussion, Dr. Kanury Rao, V. S. Co-Founder and Chief Scientific Officer of PredOmix, shared with Rahul Koul, Chief Editor of BioVoice News, how the integration of AI, big data, and other digital technologies is driving advancements in cancer research.
E N D
INNOVATING DIAGNOSTICS: A CANDID INTERVIEW WITH DR. KANURY V. S. RAO OF PREDOMIX
In an insightful discussion, Dr. Kanury Rao, V. S. Co-Founder and Chief Scientific Officer of PredOmix, shared with Rahul Koul, Chief Editor of BioVoice News, how the integration of AI, big data, and other digital technologies is driving advancements in cancer research.
The innovation-focused company, headquartered in Gurugram, Haryana, is harnessing the capabilities of artificial intelligence to create cutting-edge technologies aimed at preventive healthcare and early-stage disease detection.
How is PredOmix strengthening preventive healthcare through the use of advanced technologies like Artificial Intelligence? What sets your product OncoVeryx apart? What have been the expectations and the response so far?
Is early-stage disease detection truly achievable through digital technologies? How is your company making this possible? What are the key areas of innovation you plan to prioritize, and why? Could you share details about the ongoing R&D projects led by the company?